| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 33 | 2024 | 766 | 4.880 |
Why?
|
| tau Proteins | 17 | 2024 | 189 | 4.100 |
Why?
|
| Parkinson Disease | 22 | 2024 | 669 | 4.070 |
Why?
|
| Drosophila | 21 | 2024 | 766 | 2.180 |
Why?
|
| Drosophila Proteins | 14 | 2020 | 707 | 1.700 |
Why?
|
| Genome-Wide Association Study | 26 | 2023 | 1642 | 1.640 |
Why?
|
| alpha-Synuclein | 7 | 2023 | 114 | 1.540 |
Why?
|
| Genetic Predisposition to Disease | 23 | 2024 | 3090 | 1.470 |
Why?
|
| Drosophila melanogaster | 9 | 2019 | 738 | 1.460 |
Why?
|
| Brain | 17 | 2024 | 2943 | 1.460 |
Why?
|
| Parkinsonian Disorders | 11 | 2024 | 75 | 1.370 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2024 | 522 | 1.350 |
Why?
|
| Neurons | 16 | 2024 | 1926 | 1.270 |
Why?
|
| Aging | 11 | 2023 | 1173 | 1.150 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2023 | 2595 | 1.070 |
Why?
|
| Neurodegenerative Diseases | 5 | 2017 | 253 | 1.040 |
Why?
|
| Tauopathies | 4 | 2021 | 56 | 0.950 |
Why?
|
| Genetic Loci | 6 | 2019 | 338 | 0.880 |
Why?
|
| Cytoskeletal Proteins | 3 | 2024 | 270 | 0.840 |
Why?
|
| Wearable Electronic Devices | 2 | 2021 | 101 | 0.800 |
Why?
|
| Lysosomes | 2 | 2023 | 232 | 0.800 |
Why?
|
| Neuronal Plasticity | 1 | 2024 | 274 | 0.790 |
Why?
|
| Lysosomal Storage Diseases | 3 | 2019 | 36 | 0.780 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2021 | 6 | 0.750 |
Why?
|
| Lewy Bodies | 5 | 2021 | 11 | 0.730 |
Why?
|
| Synaptic Transmission | 2 | 2020 | 348 | 0.730 |
Why?
|
| Synapses | 1 | 2024 | 448 | 0.730 |
Why?
|
| Cognition Disorders | 6 | 2021 | 555 | 0.720 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2021 | 45 | 0.720 |
Why?
|
| DNA Transposable Elements | 2 | 2018 | 176 | 0.710 |
Why?
|
| Animals | 40 | 2024 | 33693 | 0.700 |
Why?
|
| Endosomes | 1 | 2020 | 67 | 0.680 |
Why?
|
| Postural Balance | 1 | 2021 | 124 | 0.670 |
Why?
|
| Tremor | 1 | 2021 | 129 | 0.670 |
Why?
|
| Spliceosomes | 1 | 2019 | 53 | 0.660 |
Why?
|
| 14-3-3 Proteins | 1 | 2019 | 54 | 0.650 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 117 | 0.650 |
Why?
|
| Proteostasis | 1 | 2019 | 34 | 0.640 |
Why?
|
| Nerve Degeneration | 2 | 2019 | 126 | 0.630 |
Why?
|
| Multiple System Atrophy | 1 | 2018 | 17 | 0.620 |
Why?
|
| Glucosylceramidase | 5 | 2023 | 27 | 0.620 |
Why?
|
| RNA Splicing | 1 | 2019 | 223 | 0.610 |
Why?
|
| Humans | 83 | 2024 | 122997 | 0.590 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 277 | 0.570 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2017 | 109 | 0.570 |
Why?
|
| Animals, Genetically Modified | 8 | 2023 | 316 | 0.560 |
Why?
|
| Neurofibrillary Tangles | 3 | 2017 | 26 | 0.520 |
Why?
|
| Disease Models, Animal | 10 | 2024 | 4263 | 0.510 |
Why?
|
| Cell Death | 1 | 2016 | 242 | 0.500 |
Why?
|
| Aged, 80 and over | 27 | 2024 | 6359 | 0.500 |
Why?
|
| Nervous System Diseases | 2 | 2019 | 370 | 0.500 |
Why?
|
| Genetic Variation | 9 | 2019 | 1479 | 0.450 |
Why?
|
| Amyloid beta-Peptides | 6 | 2024 | 206 | 0.430 |
Why?
|
| Neurology | 1 | 2015 | 108 | 0.430 |
Why?
|
| Genome | 2 | 2018 | 472 | 0.430 |
Why?
|
| DiGeorge Syndrome | 1 | 2013 | 79 | 0.420 |
Why?
|
| Phenotype | 10 | 2019 | 4221 | 0.420 |
Why?
|
| Apolipoprotein E4 | 2 | 2013 | 43 | 0.420 |
Why?
|
| Aged | 33 | 2024 | 19035 | 0.400 |
Why?
|
| Neuroglia | 2 | 2024 | 193 | 0.390 |
Why?
|
| Receptors, Complement | 1 | 2012 | 31 | 0.390 |
Why?
|
| Mutation | 11 | 2022 | 5773 | 0.390 |
Why?
|
| Genetic Association Studies | 7 | 2016 | 760 | 0.370 |
Why?
|
| Transcriptome | 4 | 2023 | 908 | 0.370 |
Why?
|
| Male | 43 | 2024 | 59901 | 0.370 |
Why?
|
| Female | 47 | 2024 | 65309 | 0.360 |
Why?
|
| Genotype | 14 | 2020 | 2546 | 0.360 |
Why?
|
| Genomics | 4 | 2023 | 1476 | 0.350 |
Why?
|
| Databases, Genetic | 4 | 2019 | 471 | 0.340 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 435 | 0.330 |
Why?
|
| Apoptosis | 3 | 2012 | 1783 | 0.330 |
Why?
|
| Plaque, Amyloid | 4 | 2017 | 63 | 0.310 |
Why?
|
| Disease Progression | 5 | 2024 | 2027 | 0.290 |
Why?
|
| Middle Aged | 24 | 2024 | 25931 | 0.290 |
Why?
|
| Receptors, Complement 3b | 3 | 2012 | 8 | 0.280 |
Why?
|
| Cohort Studies | 13 | 2024 | 4705 | 0.280 |
Why?
|
| Longitudinal Studies | 8 | 2021 | 1313 | 0.280 |
Why?
|
| Cognitive Dysfunction | 4 | 2024 | 222 | 0.270 |
Why?
|
| RNA Interference | 3 | 2018 | 496 | 0.260 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 376 | 0.250 |
Why?
|
| Hippocampus | 3 | 2024 | 811 | 0.250 |
Why?
|
| Cell Polarity | 3 | 2002 | 125 | 0.250 |
Why?
|
| Models, Biological | 3 | 2019 | 1442 | 0.240 |
Why?
|
| Chloramines | 1 | 2024 | 5 | 0.240 |
Why?
|
| Poison Control Centers | 1 | 2024 | 2 | 0.240 |
Why?
|
| Chlorine | 1 | 2024 | 14 | 0.240 |
Why?
|
| Age of Onset | 4 | 2020 | 581 | 0.230 |
Why?
|
| Literature, Modern | 1 | 2004 | 3 | 0.230 |
Why?
|
| Medicine in Literature | 1 | 2004 | 3 | 0.230 |
Why?
|
| Lipid Droplets | 1 | 2024 | 46 | 0.230 |
Why?
|
| Haplotypes | 3 | 2016 | 519 | 0.230 |
Why?
|
| Drama | 1 | 2004 | 11 | 0.230 |
Why?
|
| Mitochondria | 2 | 2022 | 682 | 0.230 |
Why?
|
| Dementia | 2 | 2024 | 448 | 0.230 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2023 | 7 | 0.220 |
Why?
|
| Motor Activity | 2 | 2019 | 520 | 0.210 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2001 | 89 | 0.210 |
Why?
|
| Alleles | 7 | 2019 | 1602 | 0.210 |
Why?
|
| Prospective Studies | 8 | 2024 | 6023 | 0.210 |
Why?
|
| Caenorhabditis elegans | 3 | 2017 | 223 | 0.210 |
Why?
|
| Patients | 1 | 2004 | 121 | 0.210 |
Why?
|
| Protein Interaction Maps | 2 | 2021 | 77 | 0.210 |
Why?
|
| Proteomics | 3 | 2021 | 480 | 0.210 |
Why?
|
| Risk Factors | 14 | 2024 | 9974 | 0.200 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 864 | 0.200 |
Why?
|
| Surgical Procedures, Operative | 1 | 2004 | 182 | 0.200 |
Why?
|
| Peptide Fragments | 3 | 2016 | 747 | 0.190 |
Why?
|
| Astrocytes | 2 | 2024 | 250 | 0.190 |
Why?
|
| Exome | 5 | 2017 | 1041 | 0.190 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2019 | 42 | 0.190 |
Why?
|
| Apolipoproteins E | 7 | 2017 | 190 | 0.190 |
Why?
|
| Cytoskeleton | 2 | 2011 | 178 | 0.180 |
Why?
|
| Insect Proteins | 2 | 2002 | 98 | 0.180 |
Why?
|
| Mice | 7 | 2024 | 17469 | 0.180 |
Why?
|
| Proteome | 2 | 2019 | 233 | 0.180 |
Why?
|
| Case-Control Studies | 8 | 2020 | 3259 | 0.180 |
Why?
|
| Gene Regulatory Networks | 3 | 2020 | 353 | 0.170 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 1760 | 0.170 |
Why?
|
| Cathepsin B | 1 | 2020 | 10 | 0.170 |
Why?
|
| Membrane Proteins | 4 | 2016 | 1524 | 0.170 |
Why?
|
| Cell Physiological Phenomena | 1 | 1999 | 16 | 0.170 |
Why?
|
| Lewy Body Disease | 1 | 2020 | 18 | 0.170 |
Why?
|
| Cerebrospinal Fluid | 1 | 2020 | 92 | 0.170 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2019 | 17 | 0.170 |
Why?
|
| Burnout, Professional | 1 | 2021 | 115 | 0.170 |
Why?
|
| Helminth Proteins | 1 | 2000 | 101 | 0.170 |
Why?
|
| Penetrance | 1 | 2020 | 103 | 0.170 |
Why?
|
| Adult | 14 | 2024 | 28980 | 0.160 |
Why?
|
| Accelerometry | 1 | 2019 | 59 | 0.160 |
Why?
|
| Microglia | 1 | 2020 | 95 | 0.160 |
Why?
|
| Oxidative Stress | 1 | 2024 | 796 | 0.160 |
Why?
|
| Polymorphism, Genetic | 2 | 2012 | 810 | 0.160 |
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 2 | 2019 | 19 | 0.150 |
Why?
|
| Cathepsin D | 1 | 2017 | 16 | 0.150 |
Why?
|
| Organic Anion Transporters | 1 | 2017 | 16 | 0.150 |
Why?
|
| Acid Ceramidase | 1 | 2017 | 5 | 0.150 |
Why?
|
| Substantia Nigra | 2 | 2021 | 33 | 0.150 |
Why?
|
| Proteins | 3 | 2016 | 1038 | 0.140 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2017 | 6 | 0.140 |
Why?
|
| Symporters | 1 | 2017 | 66 | 0.140 |
Why?
|
| Age Factors | 5 | 2016 | 2801 | 0.140 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 101 | 0.140 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 3 | 2012 | 5 | 0.140 |
Why?
|
| alpha Catenin | 1 | 2016 | 6 | 0.140 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 2837 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 1067 | 0.140 |
Why?
|
| Tropomyosin | 1 | 2016 | 26 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 3 | 2020 | 1115 | 0.140 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2016 | 40 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 350 | 0.140 |
Why?
|
| Mice, Knockout | 1 | 2024 | 3710 | 0.140 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 96 | 0.140 |
Why?
|
| Microelectrodes | 1 | 2016 | 38 | 0.130 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2016 | 13 | 0.130 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2016 | 35 | 0.130 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 119 | 0.130 |
Why?
|
| Electroretinography | 1 | 2016 | 116 | 0.130 |
Why?
|
| Tenascin | 1 | 2016 | 35 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2016 | 554 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2016 | 167 | 0.120 |
Why?
|
| Essential Tremor | 1 | 2016 | 90 | 0.120 |
Why?
|
| Vision, Ocular | 1 | 2016 | 123 | 0.120 |
Why?
|
| Membrane Potentials | 1 | 2016 | 304 | 0.120 |
Why?
|
| Cognition | 4 | 2016 | 736 | 0.120 |
Why?
|
| Physicians | 1 | 2021 | 583 | 0.120 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 2533 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2020 | 766 | 0.120 |
Why?
|
| Atrophy | 2 | 2012 | 225 | 0.120 |
Why?
|
| Software | 1 | 2019 | 677 | 0.120 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2016 | 213 | 0.120 |
Why?
|
| Receptors, Notch | 1 | 2016 | 202 | 0.120 |
Why?
|
| Verbal Learning | 1 | 2014 | 66 | 0.120 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 469 | 0.120 |
Why?
|
| Harm Reduction | 1 | 2014 | 9 | 0.120 |
Why?
|
| Executive Function | 1 | 2015 | 104 | 0.120 |
Why?
|
| Arteriolosclerosis | 1 | 2013 | 2 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 225 | 0.110 |
Why?
|
| Infarction | 1 | 2013 | 23 | 0.110 |
Why?
|
| CD11b Antigen | 1 | 2013 | 37 | 0.110 |
Why?
|
| Follow-Up Studies | 6 | 2024 | 5031 | 0.110 |
Why?
|
| Integrins | 1 | 2013 | 81 | 0.110 |
Why?
|
| Gene Frequency | 2 | 2012 | 714 | 0.110 |
Why?
|
| Retina | 1 | 2016 | 457 | 0.100 |
Why?
|
| Locus Coeruleus | 1 | 2012 | 22 | 0.100 |
Why?
|
| Time Perception | 1 | 2012 | 11 | 0.100 |
Why?
|
| Period Circadian Proteins | 1 | 2012 | 28 | 0.100 |
Why?
|
| HIV Infections | 1 | 2024 | 1864 | 0.100 |
Why?
|
| Microtubules | 3 | 2003 | 197 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 149 | 0.100 |
Why?
|
| Memory Disorders | 1 | 2014 | 235 | 0.100 |
Why?
|
| Base Sequence | 1 | 2017 | 3093 | 0.100 |
Why?
|
| Memory, Episodic | 1 | 2012 | 25 | 0.100 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2012 | 13 | 0.100 |
Why?
|
| Cells, Cultured | 4 | 2024 | 3050 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2016 | 845 | 0.100 |
Why?
|
| Residence Characteristics | 1 | 2014 | 266 | 0.100 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2011 | 37 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2012 | 93 | 0.100 |
Why?
|
| Odds Ratio | 2 | 2012 | 1245 | 0.090 |
Why?
|
| Selection, Genetic | 1 | 2012 | 155 | 0.090 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2011 | 24 | 0.090 |
Why?
|
| Endocytosis | 1 | 2011 | 124 | 0.090 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 10 | 0.090 |
Why?
|
| Brain Mapping | 1 | 2013 | 397 | 0.090 |
Why?
|
| Neurofibrils | 1 | 2010 | 2 | 0.090 |
Why?
|
| Clusterin | 1 | 2010 | 9 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 269 | 0.090 |
Why?
|
| Neurites | 1 | 2010 | 44 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2011 | 4507 | 0.090 |
Why?
|
| Peptides | 2 | 2003 | 798 | 0.090 |
Why?
|
| Genetic Testing | 2 | 2013 | 995 | 0.080 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2016 | 121 | 0.080 |
Why?
|
| Quantitative Trait Loci | 1 | 2011 | 282 | 0.080 |
Why?
|
| Young Adult | 5 | 2024 | 8840 | 0.080 |
Why?
|
| Risk | 3 | 2017 | 750 | 0.080 |
Why?
|
| Amyloid | 2 | 2024 | 65 | 0.080 |
Why?
|
| Protein Kinases | 3 | 2007 | 330 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 423 | 0.080 |
Why?
|
| Species Specificity | 2 | 2020 | 549 | 0.080 |
Why?
|
| Neurogenesis | 2 | 2020 | 196 | 0.070 |
Why?
|
| Herpes Zoster Oticus | 1 | 2007 | 1 | 0.070 |
Why?
|
| Proline-Directed Protein Kinases | 1 | 2007 | 1 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2021 | 739 | 0.070 |
Why?
|
| Multiple Sclerosis | 1 | 2010 | 334 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 227 | 0.070 |
Why?
|
| Neuropathology | 2 | 2017 | 7 | 0.070 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2007 | 48 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2013 | 854 | 0.070 |
Why?
|
| Cell Membrane | 3 | 2011 | 459 | 0.070 |
Why?
|
| DNA-Binding Proteins | 3 | 2018 | 2048 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2007 | 100 | 0.060 |
Why?
|
| Inhalation Exposure | 1 | 2024 | 36 | 0.060 |
Why?
|
| Disinfectants | 1 | 2024 | 25 | 0.060 |
Why?
|
| Depression | 1 | 2013 | 1224 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 342 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2024 | 234 | 0.060 |
Why?
|
| Synucleins | 1 | 2003 | 13 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2007 | 333 | 0.060 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2003 | 21 | 0.060 |
Why?
|
| Ataxins | 1 | 2003 | 114 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2003 | 68 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2006 | 611 | 0.050 |
Why?
|
| Rats | 2 | 2024 | 3629 | 0.050 |
Why?
|
| Ataxin-1 | 1 | 2003 | 167 | 0.050 |
Why?
|
| Epithelium | 1 | 2003 | 366 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2003 | 194 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 1267 | 0.050 |
Why?
|
| Wings, Animal | 1 | 2002 | 32 | 0.050 |
Why?
|
| Transgenes | 1 | 2003 | 326 | 0.050 |
Why?
|
| Feedback, Physiological | 1 | 2002 | 69 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 287 | 0.050 |
Why?
|
| Oocytes | 2 | 2001 | 290 | 0.050 |
Why?
|
| Autopsy | 2 | 2012 | 110 | 0.050 |
Why?
|
| Chicago | 1 | 2021 | 21 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2014 | 771 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 481 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2013 | 1801 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 1303 | 0.050 |
Why?
|
| Oogenesis | 1 | 2001 | 52 | 0.050 |
Why?
|
| Emotions | 1 | 2024 | 364 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2024 | 15930 | 0.050 |
Why?
|
| Independent Living | 1 | 2021 | 65 | 0.050 |
Why?
|
| Interleukin-3 | 1 | 2000 | 17 | 0.040 |
Why?
|
| Phosphoproteins | 2 | 2002 | 399 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2015 | 923 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 191 | 0.040 |
Why?
|
| Sample Size | 1 | 2020 | 85 | 0.040 |
Why?
|
| Mast Cells | 1 | 2000 | 74 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 278 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2013 | 1610 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2019 | 12 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 1005 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2016 | 1102 | 0.040 |
Why?
|
| Niemann-Pick Diseases | 1 | 2019 | 2 | 0.040 |
Why?
|
| Galactosylceramidase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Sandhoff Disease | 1 | 2019 | 3 | 0.040 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2019 | 4 | 0.040 |
Why?
|
| Mucopolysaccharidosis III | 1 | 2019 | 13 | 0.040 |
Why?
|
| United States | 2 | 2024 | 10595 | 0.040 |
Why?
|
| Proton-Translocating ATPases | 1 | 2019 | 16 | 0.040 |
Why?
|
| Gaucher Disease | 1 | 2019 | 12 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 804 | 0.040 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 12 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 185 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 326 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 1999 | 142 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 412 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 312 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 1212 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 285 | 0.040 |
Why?
|
| Argonaute Proteins | 1 | 2018 | 24 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 3510 | 0.040 |
Why?
|
| Prevalence | 1 | 2024 | 2393 | 0.040 |
Why?
|
| K562 Cells | 1 | 2018 | 95 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2018 | 112 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2000 | 3871 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 191 | 0.040 |
Why?
|
| Databases, Nucleic Acid | 1 | 2018 | 69 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 1581 | 0.040 |
Why?
|
| Actins | 1 | 1999 | 341 | 0.040 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2016 | 2 | 0.040 |
Why?
|
| Detergents | 1 | 2016 | 24 | 0.040 |
Why?
|
| Iceland | 1 | 2016 | 11 | 0.030 |
Why?
|
| Gene Library | 1 | 2018 | 221 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2016 | 54 | 0.030 |
Why?
|
| Adolescent | 3 | 2024 | 19029 | 0.030 |
Why?
|
| Diagnosis | 1 | 2016 | 29 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 142 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2016 | 243 | 0.030 |
Why?
|
| COS Cells | 1 | 2016 | 273 | 0.030 |
Why?
|
| Child | 3 | 2024 | 24144 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 167 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 217 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 409 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2007 | 619 | 0.030 |
Why?
|
| Claudin-5 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2018 | 475 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1998 | 549 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 988 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 330 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1695 | 0.030 |
Why?
|
| Sulfotransferases | 1 | 2014 | 27 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2014 | 93 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2015 | 169 | 0.030 |
Why?
|
| Biomarkers | 2 | 2020 | 2940 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 671 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 167 | 0.030 |
Why?
|
| Introns | 1 | 2015 | 302 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 346 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1684 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1294 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 2820 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2013 | 83 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2012 | 11 | 0.030 |
Why?
|
| Computational Biology | 1 | 2018 | 799 | 0.030 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2012 | 51 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 110 | 0.030 |
Why?
|
| Receptor, EphA1 | 1 | 2012 | 2 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2013 | 140 | 0.030 |
Why?
|
| Actigraphy | 1 | 2012 | 44 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2012 | 56 | 0.030 |
Why?
|
| Serine | 1 | 2013 | 174 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 119 | 0.030 |
Why?
|
| Cell Count | 1 | 2012 | 248 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2011 | 1 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 1741 | 0.020 |
Why?
|
| Clathrin | 1 | 2011 | 24 | 0.020 |
Why?
|
| Secretory Pathway | 1 | 2011 | 11 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2002 | 2698 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2848 | 0.020 |
Why?
|
| Glutamates | 1 | 2011 | 68 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 153 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1569 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 280 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2011 | 122 | 0.020 |
Why?
|
| HLA-B44 Antigen | 1 | 2010 | 1 | 0.020 |
Why?
|
| HLA-B Antigens | 1 | 2010 | 30 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 1596 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 229 | 0.020 |
Why?
|
| Frizzled Receptors | 2 | 2002 | 16 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 414 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 2391 | 0.020 |
Why?
|
| Dishevelled Proteins | 2 | 2002 | 43 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 368 | 0.020 |
Why?
|
| Monocytes | 1 | 2012 | 347 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 607 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 239 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2013 | 417 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 4490 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 298 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 6198 | 0.020 |
Why?
|
| Cytoplasm | 2 | 2002 | 288 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 274 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2010 | 204 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 12286 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 467 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2013 | 798 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2002 | 893 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1011 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 3047 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2024 | 13819 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2013 | 811 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2002 | 281 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 1254 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 1993 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 767 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 152 | 0.020 |
Why?
|
| Alanine | 1 | 2007 | 181 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 123 | 0.020 |
Why?
|
| Stroke | 1 | 2013 | 958 | 0.020 |
Why?
|
| Eye | 1 | 2007 | 226 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2003 | 64 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2006 | 428 | 0.010 |
Why?
|
| Body Patterning | 1 | 2003 | 122 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 2577 | 0.010 |
Why?
|
| Pupa | 1 | 2002 | 21 | 0.010 |
Why?
|
| LIM Domain Proteins | 1 | 2002 | 59 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1684 | 0.010 |
Why?
|
| Epistasis, Genetic | 1 | 2002 | 91 | 0.010 |
Why?
|
| Nerve Endings | 1 | 2001 | 8 | 0.010 |
Why?
|
| Neuropil | 1 | 2001 | 10 | 0.010 |
Why?
|
| Vacuoles | 1 | 2001 | 23 | 0.010 |
Why?
|
| Cell Fusion | 1 | 2001 | 38 | 0.010 |
Why?
|
| Microtubule Proteins | 1 | 2001 | 27 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2001 | 83 | 0.010 |
Why?
|
| Meiosis | 1 | 2001 | 115 | 0.010 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2000 | 5 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2000 | 6 | 0.010 |
Why?
|
| Phosphopeptides | 1 | 2000 | 27 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 2000 | 23 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2000 | 29 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 1063 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 469 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 347 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 317 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2002 | 257 | 0.010 |
Why?
|
| Xenopus | 1 | 1998 | 107 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 1998 | 60 | 0.010 |
Why?
|
| Wnt1 Protein | 1 | 1998 | 71 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 1313 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 1068 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 769 | 0.010 |
Why?
|
| Biological Transport | 1 | 1998 | 347 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 12087 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 1390 | 0.010 |
Why?
|
| Cell Line | 1 | 2000 | 2779 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2001 | 1915 | 0.010 |
Why?
|